PRP. Stem cells. Bone marrow concentrate. Peptides. Longevity medicine.
Patients are asking about regenerative therapies long before many physicians have had formal training in them.
In this episode, leaders in orthobiologics tackle one of the most controversial questions in sports medicine:
How much of the excitement is supported by evidence, and how much is driven by marketing, social media, and public demand?
The discussion explores certification, patient education, surgical alternatives, biologic augmentation, regenerative orthopedics, and the future of musculoskeletal care.
One theme emerged repeatedly:
The conversation is no longer whether patients are interested.
They already are.
The challenge now is making sure the science keeps pace with the enthusiasm.
SUBSCRIBE TO OUR PODCAST → https://www.doctorsonsocialmedia.com/podcast
FIND AN EXPERT IN OUR DIRECTORIES → https://www.doctorsonsocialmedia.com/directories
Host:
Guest:
Producer: